(Q38018808)

27 August 2017

title

Inflammatory cytokines in heart failure: mediators and markers (English)

1 reference

27 August 2017

0 references

0 references

6

Pål Aukrust

0 references

Thor Ueland

series ordinal

2

object named as

Thor Ueland

1 reference

27 August 2017

1

Lars Gullestad

1 reference

27 August 2017

5

Arne Yndestad

1 reference

27 August 2017

3

Leif Erik Vinge

1 reference

27 August 2017

Alexandra Vanessa Finsen

series ordinal

4

object named as

Alexandra Finsen

1 reference

27 August 2017

language of work or name

English

0 references

publication date

12 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

122

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

23-35

1 reference

Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure

27 August 2017

cites work

1 reference

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects

21 January 2018

1 reference

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta

21 January 2018

1 reference

When are pro-inflammatory cytokines SAFE in heart failure?

21 January 2018

1 reference

Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling

21 January 2018

1 reference

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum

21 January 2018

1 reference

T lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosis

21 January 2018

1 reference

Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats

21 January 2018

1 reference

IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice

21 January 2018

1 reference

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

21 January 2018

1 reference

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure

21 January 2018

1 reference

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

21 January 2018

1 reference

C-reactive protein in heart failure: prognostic value and the effect of valsartan

21 January 2018

1 reference

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

21 January 2018

1 reference

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

21 January 2018

1 reference

The signaling adaptors and pathways activated by TNF superfamily

21 January 2018

1 reference

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial

21 January 2018

1 reference

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

21 January 2018

1 reference

The regulation of inflammation by galectin-3.

21 January 2018

1 reference

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

21 January 2018

1 reference

Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).

21 January 2018

1 reference

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

21 January 2018

1 reference

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study

21 January 2018

1 reference

Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy.

21 January 2018

1 reference

Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial

21 January 2018

1 reference

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

Pattern recognition receptors and inflammation

21 January 2018

1 reference

Nonresolving inflammation

21 January 2018

1 reference

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

21 January 2018

1 reference

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

21 January 2018

1 reference

Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes

21 January 2018

1 reference

Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart.

21 January 2018

1 reference

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

Mechanisms of disease: Toll-like receptors in cardiovascular disease

21 January 2018

1 reference

The inflammasomes: guardians of the body

21 January 2018

1 reference

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

21 January 2018

1 reference

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

Requirement of MIP-1 alpha for an inflammatory response to viral infection.

21 January 2018

1 reference

Chemokines beyond inflammation

21 January 2018

1 reference

Fractalkine: a novel cardiac chemokine?

21 January 2018

1 reference

Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling

21 January 2018

1 reference

Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload

21 January 2018

1 reference

Biology of the TRANCE axis

21 January 2018

1 reference

IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure.

21 January 2018

1 reference

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization

21 January 2018

1 reference

The effect of a single dose of osteoprotegerin in postmenopausal women

21 January 2018

1 reference

Osteoporosis: now and the future

21 January 2018

1 reference

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

21 January 2018

1 reference

Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha

21 January 2018

1 reference

Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

21 January 2018

1 reference

TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.

21 January 2018

1 reference

Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.

21 January 2018

1 reference

TIMP-3 deficiency leads to dilated cardiomyopathy.

21 January 2018

1 reference

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

21 January 2018

1 reference

Making sense of latent TGFbeta activation

21 January 2018

1 reference

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

21 January 2018

1 reference

Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.

21 January 2018

1 reference

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice

21 January 2018

1 reference

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338166

1 reference

27 August 2017

1 reference